Clinical Trial Update: Natrecor for Pulmonary Hypertension in Lung Transplants [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating natrecor for pulmonary hypertension in lung transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Pulmonary Hypertension | Phase 4 | Status: COMPLETED